But Zontag points out that its hard to say from these findings alone
The reason GLP-1 telehealth platforms exist is the same reason patients are using them at scale: traditional routes to prescription weight loss medication are expensive, slow, often unavailable, and structured around insurance systems that have historically classified obesity treatment as an elective rather than a chronic metabolic condition requiring clinical management - a classification that major professional societies have spent years working to overturn
Risk of recurrence The case of the patient whose allodynia recurred six months after initial resolution raises the possibility that semaglutide-associated allodynia can recur
Funding Work in the authors groups has been supported by the National Institute for Translational Neuroscience (Brazil), the Brazilian agencies Conselho Nacional de Desenvolvimento Cientfico e Tecnolgico (CNPq) and Fundao de Amparo Pesquisa do Estado do Rio de Janeiro (FAPERJ) (to STF and FDF), and Alzheimer Society Canada and Weston Brain Institute (to FDF)
My Take: We are closing the gap between pharmacological weight management and bariatric surgery outcomes
Understanding the stability limitations of reconstituted Retatrutide Powder is essential for facilities that prepare injectable solutions for clinical use, research protocols, or patient-specific compounding applications
